These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiphospholipid antibodies: is there a role in cardiac valvular disease and its thromboembolic complications? Nardone Soscia P; Romain PL Cardiology; 1992; 80(1):1-6. PubMed ID: 1555211 [No Abstract] [Full Text] [Related]
5. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus. Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055 [No Abstract] [Full Text] [Related]
8. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome. Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766 [TBL] [Abstract][Full Text] [Related]
9. [Classification criteria for the antiphospholipid syndrome--the next modification]. Zimmermann-Górska I Pol Arch Med Wewn; 2006 May; 115(5):396-400. PubMed ID: 17195350 [No Abstract] [Full Text] [Related]
10. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus]. Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724 [TBL] [Abstract][Full Text] [Related]
11. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096 [TBL] [Abstract][Full Text] [Related]
12. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome]. Alekberova ZS; Nasonov EL; Stoianovich LZ Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383 [No Abstract] [Full Text] [Related]
14. Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Mattos P; Santiago MB Clin Rheumatol; 2011 Feb; 30(2):165-71. PubMed ID: 21207090 [TBL] [Abstract][Full Text] [Related]
15. On the catastrophic adjective for the antiphospholipid syndrome. Alarcon-Segovia D Clin Exp Rheumatol; 1993; 11(6):587-8. PubMed ID: 8093129 [No Abstract] [Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
17. Chilblains and antiphospholipid antibodies: report of four cases and review of the literature. Lutz V; Cribier B; Lipsker D Br J Dermatol; 2010 Sep; 163(3):645-6. PubMed ID: 20426783 [No Abstract] [Full Text] [Related]
18. [Involvement of cardiac valves in antiphospholipid syndrome]. Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087 [TBL] [Abstract][Full Text] [Related]
19. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066 [TBL] [Abstract][Full Text] [Related]
20. [Immunopathology of the antiphospholipid syndrome]. Stojanović Lj; Alekbergova Z; Kalasnikova Lj; Nasonov E; Manujlova L; Sokolov V; Stanić M Srp Arh Celok Lek; 1994; 122 Suppl 1():53-6. PubMed ID: 18173188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]